• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

链脲佐菌素诱导的糖尿病大鼠的血小板存活情况

Platelet survival in streptozotocin-induced diabetic rats.

作者信息

Winocour P D, Laimins M, Colwell J A

出版信息

Thromb Haemost. 1984 Jul 29;51(3):307-12.

PMID:6495251
Abstract

Platelet survival in diabetes mellitus may be decreased or normal, and it is not clear whether altered platelet survival is due to a platelet or to a non-platelet defect. Therefore, platelet survival studies were performed at intervals up to 28 days in streptozotocin-induced diabetic and normal rats, using washed platelets from diabetic or normal animals. When compared to platelets from control rats, there was a significant decrease in platelet survival when platelets from 7 and 14 day diabetic rats were injected into normal controls or into diabetic rats. After 28 days of diabetes, platelet survival in diabetic rats was significantly lengthened, whether the platelets came from control or diabetic rats. Conclusions. Shortened platelet survival in the diabetic rat is caused initially by a platelet defect. Later, non-platelet factors become dominant. These findings may help explain reported discrepancies in results of platelet survival in diabetes mellitus.

摘要

糖尿病患者的血小板存活时间可能缩短或正常,目前尚不清楚血小板存活时间的改变是由于血小板本身还是非血小板缺陷所致。因此,利用链脲佐菌素诱导的糖尿病大鼠和正常大鼠,每隔28天进行一次血小板存活研究,使用糖尿病或正常动物的洗涤血小板。与对照大鼠的血小板相比,将7天和14天糖尿病大鼠的血小板注入正常对照或糖尿病大鼠体内时,血小板存活时间显著缩短。糖尿病28天后,无论血小板来自对照大鼠还是糖尿病大鼠,糖尿病大鼠的血小板存活时间均显著延长。结论。糖尿病大鼠血小板存活时间缩短最初是由血小板缺陷引起的。后来,非血小板因素占主导地位。这些发现可能有助于解释糖尿病患者血小板存活研究结果中报道的差异。

相似文献

1
Platelet survival in streptozotocin-induced diabetic rats.链脲佐菌素诱导的糖尿病大鼠的血小板存活情况
Thromb Haemost. 1984 Jul 29;51(3):307-12.
2
Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.糖尿病大鼠体外血小板功能及血浆血管性血友病因子活性(VIIIR:WF)和因子VIII相关抗原(VIIIR:Ag)变化的时间进程。
J Lab Clin Med. 1983 Nov;102(5):795-804.
3
Reduced platelet-mediated and enhanced leukocyte-mediated fibrinolysis in experimentally induced diabetes in rats.
J Lab Clin Med. 1985 May;105(5):613-8.
4
High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study.高糖导致链脲佐菌素诱导的糖尿病大鼠对阿司匹林不敏感:一项多参数聚集研究。
Blood Coagul Fibrinolysis. 2006 Mar;17(2):113-24. doi: 10.1097/01.mbc.0000203862.85610.ac.
5
Changes in the properties of platelets from rats with experimentally induced shortened platelet survival.实验性诱导血小板存活期缩短的大鼠血小板特性的变化。
J Lab Clin Med. 1983 Feb;101(2):175-82.
6
The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.链脲佐菌素诱导的糖尿病对通过阻抗聚集法测定的血小板聚集和血小板分泌的影响:一氧化氮的可能作用。
J Assoc Acad Minor Phys. 1995;6(3):100-4.
7
Shwartzman reaction in streptozotocin-induced diabetic rats.链脲佐菌素诱导的糖尿病大鼠中的施瓦茨曼反应。
Lab Invest. 1984 May;50(5):565-70.
8
Platelet thromboxane A2 synthesizing capacity is enhanced by fasting but diminished by diabetes mellitus in the rat.
Diabetes Res. 1988 Aug;8(4):177-81.
9
Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).色素上皮衍生因子(PEDF)通过阻断晚期糖基化终产物(AGEs)的有害作用来预防糖尿病大鼠的血小板活化和聚集。
Diabetes Metab Res Rev. 2009 Mar;25(3):266-71. doi: 10.1002/dmrr.906.
10
Increased platelet aggregation and fatty acid oxidation in diabetic rats.糖尿病大鼠血小板聚集增加及脂肪酸氧化增强。
Biochem Mol Biol Int. 1993 May;30(1):177-85.

引用本文的文献

1
Vitamin D₃ prevents the increase in ectonucleotidase activities and ameliorates lipid profile in type 1 diabetic rats.维生素D₃可预防1型糖尿病大鼠外核苷酸酶活性增加,并改善其血脂状况。
Mol Cell Biochem. 2015 Jul;405(1-2):11-21. doi: 10.1007/s11010-015-2390-6. Epub 2015 Apr 17.
2
Antiplatelet agents and diabetic vascular disease.抗血小板药物与糖尿病血管疾病
Trans Am Clin Climatol Assoc. 1987;98:119-27.
3
Increased platelet volume--sign of impaired thrombopoiesis in diabetes mellitus.血小板体积增加——糖尿病中血小板生成受损的迹象。
Klin Wochenschr. 1989 Feb 15;67(4):253-9. doi: 10.1007/BF01717328.